Open AccessSentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost
Author(s) -
Yinin Hu,
Andrew Briggs,
Renee L. Gennarelli,
Edmund K. Bartlett,
Charlotte E. Ariyan,
Daniel G. Coit,
Mary Sue Brady
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-08558-8
Subject(s) - medicine , sentinel lymph node , melanoma , biopsy , lymphadenectomy , surgical oncology , sentinel node , surgery , adjuvant therapy , lymph node , cancer , chemotherapy , breast cancer , cancer research
The purpose of this study is to report the additional prognostic information and cost associated with sentinel lymph node biopsy (SLNB) for patients with T1b melanoma.